Liver

Latest Articles

Exploring the Relationship Between Muscle Mass and NAFLD

By

Tori Rodriguez, MA, LPC, AHC

The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.

Oral PXL770 Associated With Only Modest Decrease in Liver Fat Content in NAFLD

By

Colby Stong

Investigators assessed the safety and efficacy of PXL770 in reducing liver fat content in patients with nonalcoholic fatty liver disease.

Green-Mediterranean Diet May Reduce NAFLD

By

Dhivya Haridass, PhD

Researchers examined the effect of a green-Mediterranean diet enriched with plant-based polyphenols and less red and processed meat on reduction of liver fat.

Prevalence of Primary Sclerosing Cholangitis in IBD Explored

The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease.

Increased Risk for Cardiovascular Events in Patients With NAFLD

By

Jennifer Champagne, PharmD, RPh, BCPS

Investigators assessed the incidence of major adverse cardiovascular events in patients with histologically-confirmed nonalcoholic fatty liver disease.

COVID-19 Vaccines Reduce Hospitalizations and Death Among Patients With Cirrhosis

By

Mary Stroka

Investigators assessed outcomes in patients with cirrhosis following receipt of the Pfizer or Moderna COVID-19 vaccine.

Bariatric Surgery Reduces Hepatic Steatosis in Obesity and T2D

In 77 percent of patients, the enhanced liver fibrosis score category remained stable; however, at one year, 18 percent experienced worsening of fibrosis, with no substantial difference between the groups.

Rivoceranib Designated Orphan Drug for Hepatocellular Carcinoma

By

Brian Park, PharmD

Rivoceranib is an orally administered, small molecule inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2).

A Deep Dive Into the Liver Manifestations in Rheumatic Diseases

By

Dhivya Haridass, PhD

An overview of research indicating the association between rheumatic diseases and the liver, and the management of patients with rheumatic disease with liver involvement.

Diet Supplementation With Artichoke Extract May Effectively Decrease Liver Enzymes Among Some Patients

By

Jessica Nye, PhD

Investigators assessed the effects of dietary artichoke supplementation on levels of liver enzymes.

Outcomes Improved by Carvedilol in Patients With Cirrhosis and Ascites

By

Jennifer Champagne, PharmD, RPh, BCPS

Investigators assessed the long-term outcomes of patients with cirrhosis and ascites switched from treatment with propranolol to carvedilol.

Evaluating Treatment Methods for Portal Hypertension and Cirrhosis

By

Emily Pond

Investigators compared the safety and efficacy of different treatments for patients with portal hypertension and cirrhosis.

Higher Serum Iron May Increase Liver Cancer Risk in NAFLD Patients

Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with NAFLD.

Liver Transplant Outcomes Worse for Nonoverweight NAFLD Patients

Nonoverweight patients with nonalcoholic fatty liver disease cirrhosis who are on the transplant wait list have worse pre- and post-liver transplant outcomes.

Some Patients With Cirrhosis Given Opioid Prescriptions at Outpatient Visits

Almost one in five patients with cirrhosis receive opioid prescriptions during outpatient visits.

Increasing Living Liver Donors May Reduce the Existing Disparity in Access to LT Among Women

By

Jessica Nye, PhD

Investigators aimed to determine whether availability of a living donor could overcome the disparity in access to liver transplant among women.

Novel Multikinase Inhibitor Gets Fast Track Status for Cholangiocarcinoma

By

Puja Patel

The designation is based on results from a phase 1 study that evaluated TT-00420 at different dose levels in 9 CCA patients.

Prevalence of Primary Sclerosing Cholangitis in Patients With IBD

By

Jennifer Champagne, PharmD, RPh, BCPS

Investigators assessed how certain factors influence the prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Hepatitis B Shots Advised for All US Adults Younger Than 60 Years

All U.S. adults younger than 60 years should be vaccinated against hepatitis B, the Advisory Committee on Immunization Practices recommended.

6-Month Abstinence Rule Not Associated With Better Outcomes for Liver Transplants in ALD

By

Colby Stong

Researchers investigated survival outcomes for patients with alcohol-associated liver disease undergoing early vs standard liver transplant.